G. Marchal et al., PARAMAGNETIC METALLOPORPHYRINS - INFARCT AVID CONTRAST AGENTS FOR DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION BY MRI, European radiology, 6(1), 1996, pp. 2-8
In previous experiments in tumors we demonstrated that metalloporphyri
ns are particularly avid for nonviable tumor components. This study wa
s performed to find out whether these agents can be used as MRI contra
st agents for the visualization of acute myocardial infarction (MI). A
total of 44 rats, 6 normal controls and 38 with occlusive MI (2-24 h
old), were used. Gadolinium mesoporphyrin (Gd-MP) or manganese tetraph
enylporphyrin (Mn-TPP) was intravenously injected at doses of 0.1, 0.0
5, 0.01 mmol/kg. Three to 24 h after injection, axial and coronal T1-w
eighted (TR/TE 300/15 ms) spin-echo MR images were obtained before and
after killing the animals and correlated with triphenyl tetrazolium c
hloride (TTC) histochemical preparations. The Gd-MP content in infarct
ed and noninfarcted myocardium was measured using inductively coupled
MRI plasma atomic emission spectroscopy (ICP-AES). MRI without contras
t media could not discern the MI. However, 3-24 h after injection of e
ither Gd-MP or Mn-TPP, the infarcted area was positively stained MR im
ages. This area matched well with the negative TTC-stained area on the
heart slices (r = 0.97). The contrast ratios between the infarcted ne
crotic myocardium and the noninfarcted regions varied from 150 to 300%
depending on the type of agents and doses used. Neither false-positiv
e nor false-negative findings were encountered. The metalloporphyrin c
oncentration was more than 10 time higher in the infarcted than in the
noninfarcted heart. Metalloporphyrins appear to be promising MRI cont
rast agents for detection and quantification of necrosis in MI. These
preclinical results may open new perspective in cardiac imaging.